Physician profile
Brian F Shay
NPI 1770529067
$14,451.63
in general payments reported to CMS, 2019-2025
60 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,503 · 2020: $1,142 · 2021: $1,073 · 2022: $1,309 · 2023: $1,831 · 2024: $2,107 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,424.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $3,472.95 | 2019-2025 | Xtandi, Myrbetriq |
| Axonics, INC. | $1,516.10 | 2020-2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $808.11 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $804.86 | 2019-2025 | |
| Allen Medical Systems | $800.00 | 2019 | |
| Hill-Rom Services, INC | $650.00 | 2019 | |
| Abbvie INC. | $407.81 | 2019-2024 | Botox |
| Teleflex LLC | $405.15 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $366.47 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $363.78 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $340.47 | 2019-2024 | Erleada |
| Boston Scientific Corporation | $330.50 | 2019-2025 | Axonics, Lithovue |
| Coloplast Corp | $323.17 | 2020-2024 | Porges Coloplast, Speedicath |
| Merck Sharp & Dohme LLC | $303.17 | 2020-2024 | Lynparza, Welireg, Keytruda |
| Ferring Pharmaceuticals INC. | $301.01 | 2019-2025 | Adstiladrin |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.